BMN307 (AAV PKU gene therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMN307 (AAV PKU gene therapy), covering 2024-12-12 to 2024-12-12. Get the full timeline:
Most recent: Clinical Trial Update: AAV Gene Therapy Study for Subjects with PKU [Phase 1, Phase 2]